Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Exploration of potential inhibitors for SARS‐CoV‐2 Mpro considering its mutants via structure‐based drug design, molecular docking, MD simulations, MM/PBSA, and DFT calculations
Abdulrahman Ghasemlou, Vuk Uskoković, Yahya Sefidbakht
Biotechnology and Applied Biochemistry (2022) Vol. 70, Iss. 1, pp. 439-457
Closed Access | Times Cited: 9

Showing 9 citing articles:

An overview of the vaccine platforms to combat COVID-19 with a focus on the subunit vaccines
Fatemeh Bayani, Negin Safaei Hashkavaei, Sareh Arjmand, et al.
Progress in Biophysics and Molecular Biology (2023) Vol. 178, pp. 32-49
Open Access | Times Cited: 49
AI-driven covalent drug design strategies targeting main protease (m pro ) against SARS-CoV-2: structural insights and molecular mechanisms
Mohammad Hossein Haghir Ebrahim Abadi, Abdulrahman Ghasemlou, Fatemeh Bayani, et al.
Journal of Biomolecular Structure and Dynamics (2024), pp. 1-29
Closed Access | Times Cited: 4
Assessing the Potential Contribution of In Silico Studies in Discovering Drug Candidates That Interact with Various SARS-CoV-2 Receptors
Aganze Gloire-Aimé Mushebenge, Samuel Chima Ugbaja, Nonkululeko Avril Mbatha, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 21, pp. 15518-15518
Open Access | Times Cited: 9
Molecular Modeling of Viral Type I Fusion Proteins: Inhibitors of Influenza Virus Hemagglutinin and the Spike Protein of Coronavirus
Sophia S. Borisevich, Владимир В. Зарубаев, Д. Н. Щербаков, et al.
Viruses (2023) Vol. 15, Iss. 4, pp. 902-902
Open Access | Times Cited: 7
Recent progress in artificial intelligence and machine learning for novel diabetes mellitus medications development
Qi Guo, Bo Fu, Yuan Tian, et al.
Current Medical Research and Opinion (2024) Vol. 40, Iss. 9, pp. 1483-1493
Closed Access | Times Cited: 2
In silico design of a multi-epitope vaccine against the spike and the nucleocapsid proteins of the Omicron variant of SARS-CoV-2
Fatemeh Bayani, Negin Safaei Hashkavaei, Mohammad Reza Karamian, et al.
Journal of Biomolecular Structure and Dynamics (2023) Vol. 41, Iss. 21, pp. 11748-11762
Closed Access | Times Cited: 6
Crystallographic Data Collection Using a Multilayer Monochromator on an Undulator Beamline at the Shanghai Synchrotron Radiation Facility
Chenyu Zhang, Xu Qin, Weiwei Wang, et al.
Crystals (2024) Vol. 14, Iss. 2, pp. 199-199
Open Access | Times Cited: 1
Current advances of anticancer drugs based on solubilization technology
Min Wu, Liping Wang, Xiaofang Li, et al.
Nanotechnology Reviews (2024) Vol. 13, Iss. 1
Open Access | Times Cited: 1
Structural basis of main proteases of HCoV-229E bound to inhibitor PF-07304814 and PF-07321332
Yanru Zhou, Weiwei Wang, Pei Zeng, et al.
Biochemical and Biophysical Research Communications (2023) Vol. 657, pp. 16-23
Open Access | Times Cited: 3
Page 1

Scroll to top